Aquestive Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Aquestive Therapeutics has a total shareholder equity of $-106.5M and total debt of $27.5M, which brings its debt-to-equity ratio to -25.9%. Its total assets and total liabilities are $57.4M and $163.9M respectively.
Key information
-25.9%
Debt to equity ratio
US$27.53m
Debt
| Interest coverage ratio | n/a |
| Cash | US$23.87m |
| Equity | -US$106.49m |
| Total liabilities | US$163.91m |
| Total assets | US$57.42m |
Recent financial health updates
Recent updates
Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
Apr 09Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Shares Climb 30% But Its Business Is Yet to Catch Up
Feb 28
Aquestive Therapeutics: Anaphylm's Top-Line Data Could Reveal A Game-Changer In Q1
Jan 19Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Popularity With Investors Is Under Threat From Overpricing
Jan 05Aquestive Therapeutics, Inc. (NASDAQ:AQST) Surges 63% Yet Its Low P/S Is No Reason For Excitement
Apr 17Aquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reaction
Oct 11Aquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal film
Sep 28Aquestive Therapeutics: FDA Stymies Libervant Launch
Sep 05Aquestive Therapeutics: A First Take
Aug 29Aquestive Therapeutics: Sell-Off Prompts A Change In Tactics
May 26Financial Position Analysis
Short Term Liabilities: AQST has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: AQST has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: AQST has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: AQST's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AQST has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: AQST is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital.